Pomalidomide-PEG4-CO2H

Background Introduction

Pomalidomide-PEG4-CO2H is a versatile E3 ligase ligand-linker conjugate commonly used in the design and synthesis of PROTACs (Proteolysis Targeting Chimeras) for targeted protein degradation. This molecule combines the cereblon (CRBN) ligand pomalidomide with a polyethylene glycol (PEG4) linker terminating in a carboxylic acid (CO2H) group. The flexible PEG4 spacer enhances aqueous solubility and provides optimal distance for efficient recruitment of target and E3 ligase complexes.

Mechanism

The mechanism of Pomalidomide-PEG4-CO2H lies in its function as a modular chemical handle for the assembly of heterobifunctional small molecules. Pomalidomide binds and recruits the E3 ubiquitin ligase cereblon (CRBN). The PEG4 linker acts as a flexible bridge, terminating in a reactive carboxylic acid that facilitates further chemical conjugation to target protein ligands via amide bond formation. When incorporated into a PROTAC molecule, the CRBN ligand and the target protein ligand are brought into proximity, promoting ubiquitination and subsequent proteasomal degradation of the target protein.

Applications

Pomalidomide-PEG4-CO2H is widely used in the synthesis of novel PROTAC molecules for chemical biology and drug discovery research. It enables researchers to link various target-binding ligands to the CRBN E3 ligase to develop custom protein degraders for oncology, neurodegeneration, immunology, and other therapeutic areas. This conjugate is also valuable for the structure-activity relationship (SAR) studies of linker length, flexibility, and polarity on PROTAC efficacy, making it a crucial tool in the optimization of next-generation targeted degradation therapeutics.

Pomalidomide-PEG4-CO2H serves as a versatile E3 Ligase Ligand-Linker Conjugate in PROTACs, facilitating targeted protein degradation by linking a ligand to a protein of interest. The following provides a detailed description of this molecule, highlighting its linker, ligand, and recommended target protein ligand.

Linker: The linker in this molecule is a polyethylene glycol (PEG) chain with four ethylene glycol units, offering moderate length and flexibility. This PEG4 linker enhances solubility and provides spatial separation between the ligand and the reactive site, while its non-cleavable nature ensures stability during cellular processes.

Ligand: The ligand component is derived from pomalidomide, a thalidomide analog known for its high affinity to the cereblon E3 ligase. Its structural characteristics include a glutarimide moiety, which is essential for cereblon binding, making it effective for targeted protein degradation applications.

Reactive Site: The reactive site is a terminal carboxylic acid (CO2H) group, which can couple with target protein ligands through amide bond formation. This site is amenable to reactions such as carbodiimide-mediated coupling, providing a robust and efficient connection to the target protein ligand.

Recommended Target Protein Ligand: The ideal warhead for this molecule is an amine-containing compound, which can form stable amide linkages with the carboxylic acid group. This compatibility allows for the design of PROTACs targeting proteins with exposed lysine residues, facilitating selective degradation and offering potential applications in studying protein function and regulation.